MusclePharm Corp. Company Profile (OTCMKTS:MSLP)

About MusclePharm Corp. (OTCMKTS:MSLP)

MusclePharm Corp. logoMusclePharm Corporation is a performance lifestyle company. The Company develops, manufactures, markets and distributes branded nutritional supplements. The Company offers a range of powders, capsules, tablets and gels. The Company's portfolio of brands targets various types of fitness enthusiasts, including professional, combat sport, weight training, bodybuilding, running, basketball, soccer, cross fit, golf, tennis, volleyball and other active lifestyle activities. The MusclePharm Sport Series includes supplements that cover the needs of athletes, including their workout needs. MusclePharm Hybrid Series products include Assault, Amino1 and Combat Protein Powder. FitMiss products are designed and formulated for the active woman's lifestyle utilizing ingredients that cover the range of busy women's needs, including weight loss, multi-vitamins, protein shakes, detox, skin care and pre-workout energy mixes. MusclePharm Core products include BCAA 3:1:2, CLA Core and Fish Oil.

Industry, Sector and Symbol:
  • Sector: Consumer Staples
  • Industry: Personal Services
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:MSLP
  • CUSIP: N/A
  • Web:
  • Market Cap: $18.83 million
  • Outstanding Shares: 14,481,000
Average Prices:
  • 50 Day Moving Avg: $1.48
  • 200 Day Moving Avg: $1.88
  • 52 Week Range: $1.20 - $2.40
  • Trailing P/E Ratio: 17.11
  • Foreward P/E Ratio: Infinity
  • P/E Growth: -0.10
Sales & Book Value:
  • Annual Revenue: $108.92 million
  • Price / Sales: 0.16
  • Book Value: ($0.69) per share
  • Price / Book: -1.79
  • EBIDTA: ($6,250,000.00)
  • Net Margins: 0.94%
  • Return on Equity: -51.38%
  • Return on Assets: -9.40%
  • Current Ratio: 0.68%
  • Quick Ratio: 0.52%
  • Average Volume: 16,338 shs.
  • Beta: 2.43

Frequently Asked Questions for MusclePharm Corp. (OTCMKTS:MSLP)

What is MusclePharm Corp.'s stock symbol?

MusclePharm Corp. trades on the OTCMKTS under the ticker symbol "MSLP."

How were MusclePharm Corp.'s earnings last quarter?

MusclePharm Corp. (OTCMKTS:MSLP) issued its quarterly earnings data on Monday, August, 14th. The company reported ($0.13) EPS for the quarter, missing analysts' consensus estimates of ($0.08) by $0.05. The company had revenue of $26.19 million for the quarter, compared to analyst estimates of $28 million. MusclePharm Corp. had a negative return on equity of 51.38% and a net margin of 0.94%. View MusclePharm Corp.'s Earnings History.

When will MusclePharm Corp. make its next earnings announcement?

MusclePharm Corp. is scheduled to release their next quarterly earnings announcement on Wednesday, November, 8th 2017. View Earnings Estimates for MusclePharm Corp..

Who are some of MusclePharm Corp.'s key competitors?

Who are MusclePharm Corp.'s key executives?

MusclePharm Corp.'s management team includes the folowing people:

  • Ryan Charles Drexler, Executive Chairman of the Board, President, Chief Executive Officer
  • Douglas West, Interim Principal Financial Officer, Interim Principal Accounting Officer
  • Brian Casutto, Executive Vice President - Sales and Operations, Director
  • Brian Cavanaugh, Senior Vice President - Retail and Brand Strategy
  • William J. Bush CPA, Director
  • John J. Desmond, Independent Director
  • Noel Thompson, Independent Director

How do I buy MusclePharm Corp. stock?

Shares of MusclePharm Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MusclePharm Corp.'s stock price today?

One share of MusclePharm Corp. stock can currently be purchased for approximately $1.24.

MarketBeat Community Rating for MusclePharm Corp. (OTCMKTS MSLP)
Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  13 (Vote Outperform)
Underperform Votes:  17 (Vote Underperform)
Total Votes:  30
MarketBeat's community ratings are surveys of what our community members think about MusclePharm Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for MusclePharm Corp. (OTCMKTS:MSLP) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for MusclePharm Corp. (OTCMKTS:MSLP)
No equities research coverage for this company has been tracked by


Earnings History for MusclePharm Corp. (OTCMKTS:MSLP)
Earnings by Quarter for MusclePharm Corp. (OTCMKTS:MSLP)
Earnings History by Quarter for MusclePharm Corp. (OTCMKTS MSLP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/14/2017Q2 2017($0.08)($0.13)$28.00 million$26.19 millionViewN/AView Earnings Details
8/10/2015Q2 2015($0.19)($0.51)$55.00 million$50.48 millionViewN/AView Earnings Details
5/11/2015Q1 2015($0.26)($0.56)$50.00 million$41.32 millionViewN/AView Earnings Details
3/16/2015Q4 2014$0.01($1.39)$49.00 million$32.67 millionViewN/AView Earnings Details
11/14/2014Q3 2014$0.03$0.05$48.00 million$47.77 millionViewN/AView Earnings Details
8/4/2014Q2 2014($0.08)$0.03$46.74 millionViewN/AView Earnings Details
3/31/2014($0.50)($0.51)ViewN/AView Earnings Details
8/14/2013($0.34)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for MusclePharm Corp. (OTCMKTS:MSLP)
Current Year EPS Consensus Estimate: $-0.4 EPS


Dividend History for MusclePharm Corp. (OTCMKTS:MSLP)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for MusclePharm Corp. (OTCMKTS:MSLP)
Insider Ownership Percentage: 27.00%
Institutional Ownership Percentage: 10.26%
Insider Trades by Quarter for MusclePharm Corp. (OTCMKTS:MSLP)
Insider Trades by Quarter for MusclePharm Corp. (OTCMKTS:MSLP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/18/2017Wynnefield Partners Small CapMajor ShareholderBuy5,000$1.41$7,050.00View SEC Filing  
5/11/2017Amerop Holdings, Inc.Major ShareholderBuy75,000$2.00$150,000.00View SEC Filing  
4/10/2017Amerop Holdings, Inc.Major ShareholderBuy19,300$2.16$41,688.00View SEC Filing  
4/5/2017Amerop Holdings, Inc.Major ShareholderBuy87,600$2.14$187,464.00View SEC Filing  
11/24/2014Andrew J LupoDirectorBuy16,010$10.62$170,026.20View SEC Filing  
11/20/2014Andrew J LupoDirectorBuy2,200$10.10$22,220.00View SEC Filing  
11/20/2014Brad J PyattCEOBuy9,900$10.09$99,891.00View SEC Filing  
11/20/2014James J GreenwellCOOBuy1,000$9.90$9,900.00View SEC Filing  
9/19/2014Gregory MacoskoDirectorBuy1,000$13.21$13,210.00View SEC Filing  
8/22/2014Brad J PyattCEOBuy5,358$12.15$65,099.70View SEC Filing  
8/14/2014Brad J PyattCEOBuy2,500$11.48$28,700.00View SEC Filing  
8/8/2014Brad J PyattCEOBuy15,000$11.27$169,050.00View SEC Filing  
8/8/2014James J GreenwellCOOBuy1,000$11.00$11,000.00View SEC Filing  
5/12/2014Michael J DoronDirectorBuy1,000$10.14$10,140.00View SEC Filing  
5/8/2014Richard EstalellaPresidentBuy10,000$9.80$98,000.00View SEC Filing  
12/6/2013Richard EstalellaCOOBuy7,000$8.06$56,420.00View SEC Filing  
12/5/2013Brad J PyattCEOBuy11,554$8.05$93,009.70View SEC Filing  
12/5/2013Lewis Gary DavisCFOBuy2,000$7.97$15,940.00View SEC Filing  
12/5/2013Sydney R RollockCMOBuy8,335$8.11$67,596.85View SEC Filing  
11/27/2013Brad J PyattCEOBuy8,800$8.48$74,624.00View SEC Filing  
11/26/2013Lewis Gary DavisCFOBuy1,000$8.30$8,300.00View SEC Filing  
11/22/2013Richard EstalellaCOOBuy3,000$8.30$24,900.00View SEC Filing  
11/22/2013Sydney R RollockCMOBuy5,000$8.25$41,250.00View SEC Filing  
11/21/2013Brad J PyattCEOBuy4,950$8.19$40,540.50View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for MusclePharm Corp. (OTCMKTS:MSLP)
Latest Headlines for MusclePharm Corp. (OTCMKTS:MSLP)
DateHeadline logoQ&A with MusclePharm CEO Ryan Drexler Featured in - August 23 at 8:45 AM logoMusclePharm Corp. :MSLP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017 - August 17 at 3:41 PM logoEdited Transcript of MSLP earnings conference call or presentation 14-Aug-17 8:30pm GMT - August 16 at 6:23 AM logoMusclePharm's (MSLP) CEO Ryan Drexler on Q2 2017 Results - Earnings Call Transcript - August 15 at 2:16 AM logoMusclePharm Reports 2017 Second Quarter Financial Results - August 15 at 2:16 AM logoMusclePharm Corp. (OTCMKTS:MSLP) Announces Quarterly Earnings Results, Misses Expectations By $0.08 EPS - August 14 at 8:23 PM logoMusclePharm Corp. (OTCMKTS:MSLP) Scheduled to Post Earnings on Monday - August 10 at 12:20 PM logoMusclePharm Schedules 2017 Second Quarter Financial Results - August 10 at 6:05 AM logoMusclePharm Strengthens Executive Team with Addition of Chief Marketing Officer and Vice President of Finance - July 21 at 2:49 AM logoMusclePharm Appoints New Members to its Board of Directors - July 14 at 6:37 AM logoMusclePharm Partners with United States Air Force School of Aerospace Medicine - June 20 at 7:42 PM logoMusclePharm Corp (MSLP) Lowered to Sell at ValuEngine - June 4 at 7:16 AM logoMusclePharm to Present at the 7th Annual LD Micro Invitational - May 26 at 4:24 AM logoMusclePharm Corp. :MSLP-US: Earnings Analysis: Q1, 2017 By the Numbers : May 16, 2017 - May 16 at 10:25 AM logoInsider Buying: MusclePharm Corp (MSLP) Major Shareholder Purchases 75,000 Shares of Stock - May 15 at 1:26 PM logoMusclePharm Reports 2017 First Quarter Financial Results - May 10 at 6:45 PM logoMusclePharm Appoints Daniel Clark as UK Sales Director - May 8 at 12:29 PM logoMusclePharm Schedules 2017 First Quarter Financial Results - May 3 at 8:54 AM logoMusclePharm Reformulates and Relaunches Widely Popular Re-Con Post-Workout Recovery Product - April 20 at 9:54 AM logoMusclePharm And Munster Rugby Form Strategic Partnership - April 18 at 10:17 AM logoMusclePharm Corp (MSLP) Major Shareholder Amerop Holdings, Inc. Acquires 19,300 Shares - April 11 at 8:25 PM logoFamed Mountaineer Garrett Madison Joins MusclePharm as Brand Athlete - April 7 at 11:20 AM logoMusclePharm Corp (MSLP) Major Shareholder Amerop Holdings, Inc. Acquires 87,600 Shares - April 6 at 5:01 PM logoMusclePharm Strengthens Sales Team By Adding Proven Industry Veterans To Spearhead Distribution Efforts For New MusclePharm Natural Series - March 31 at 9:27 AM logoMUSCLEPHARM CORP Files SEC form 10-K, Annual Report - March 15 at 6:53 PM logoMusclePharm Issues Open Letter to Shareholders - March 15 at 6:53 PM logoMUSCLEPHARM CORP Files SEC form 8-K, Regulation FD Disclosure - March 15 at 6:53 PM logoMusclePharm Launches MusclePharm Natural Series - March 10 at 9:41 AM logo[$$] Schwarzenegger Crushes Supplements Stake - March 3 at 6:41 PM logoForm 8-K MusclePharm Corp For: Dec 02 - December 3 at 11:13 AM logoNew finance chief at MusclePharm - December 3 at 11:13 AM logoMusclePharm Announces Hiring Of New Chief Financial Officer - December 2 at 10:31 AM logoWynnefield Commends Leadership Of MusclePharm CEO - November 22 at 6:26 PM logoMusclePharm Reports Strong 2016 Third Quarter Financial Results - November 9 at 6:08 PM logoHow MusclePharm Went From Swole to Twig - October 26 at 9:38 AM logoMUSCLEPHARM CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial State - September 27 at 6:06 PM logoMusclePharm Raises $60,000+ at First Annual Submit Cancer Jiu-Jitsu Charity Event - September 23 at 10:54 AM logoMUSCLEPHARM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - August 9 at 6:33 PM logoMUSCLEPHARM CORP Files SEC form 10-Q, Quarterly Report - August 9 at 6:33 PM logoMusclePharm Reports 2016 Second Quarter Financial Results - August 9 at 6:33 PM logoMUSCLEPHARM CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders - June 29 at 4:21 PM logoMusclePharm Corporation Announces More Than $45 Million in Future Commitments Trimmed To Date - May 26 at 4:15 PM logoMUSCLEPHARM CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits - May 26 at 4:08 PM logoMUSCLEPHARM CORP Files SEC form 8-K, Termination of a Material Definitive Agreement - May 25 at 4:24 PM logoMusclePharm Reports 2016 First Quarter Financial Results - May 10 at 5:38 PM logoMUSCLEPHARM CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits - February 16 at 5:17 PM logoMUSCLEPHARM CORP Files SEC form 8-K, Other Events - February 12 at 5:30 PM logoMusclePharm Focused on Expanding Market Share in Growing Protein Sector - January 19 at 8:15 AM logoMusclePharm Completes $10 Million Financing - January 14 at 8:00 AM logoMUSCLEPHARM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial - January 14 at 7:51 AM



MusclePharm Corp. (MSLP) Chart for Thursday, September, 21, 2017

This page was last updated on 9/21/2017 by Staff